Sugentech (A253840) Stock Overview
Develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A253840 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sugentech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,060.00 |
| 52 Week High | ₩9,390.00 |
| 52 Week Low | ₩4,500.00 |
| Beta | 0.47 |
| 1 Month Change | -19.94% |
| 3 Month Change | -24.59% |
| 1 Year Change | -9.48% |
| 3 Year Change | -39.11% |
| 5 Year Change | -68.57% |
| Change since IPO | -19.04% |
Recent News & Updates
Recent updates
Is Sugentech (KOSDAQ:253840) Using Too Much Debt?
Jun 17
Is Sugentech (KOSDAQ:253840) Weighed On By Its Debt Load?
Jan 02Does Sugentech (KOSDAQ:253840) Have A Healthy Balance Sheet?
Jul 27We Like Sugentech's (KOSDAQ:253840) Returns And Here's How They're Trending
Apr 14Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly
Mar 09If You Had Bought Sugentech (KOSDAQ:253840) Stock A Year Ago, You Could Pocket A 139% Gain Today
Feb 02
Is Sugentech (KOSDAQ:253840) The Next Multi-Bagger?
Dec 29Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly
Dec 03Shareholder Returns
| A253840 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0.4% | -0.4% | -1.6% |
| 1Y | -9.5% | -5.6% | 106.6% |
Return vs Industry: A253840 underperformed the KR Medical Equipment industry which returned -5.6% over the past year.
Return vs Market: A253840 underperformed the KR Market which returned 106.6% over the past year.
Price Volatility
| A253840 volatility | |
|---|---|
| A253840 Average Weekly Movement | 6.8% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in KR Market | 15.3% |
| 10% least volatile stocks in KR Market | 4.2% |
Stable Share Price: A253840 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A253840's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 144 | Son Mi | sugentech.com |
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products.
Sugentech Inc. Fundamentals Summary
| A253840 fundamental statistics | |
|---|---|
| Market cap | ₩77.37b |
| Earnings (TTM) | -₩20.81b |
| Revenue (TTM) | ₩9.01b |
Is A253840 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A253840 income statement (TTM) | |
|---|---|
| Revenue | ₩9.01b |
| Cost of Revenue | ₩9.65b |
| Gross Profit | -₩633.53m |
| Other Expenses | ₩20.17b |
| Earnings | -₩20.81b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.36k |
| Gross Margin | -7.03% |
| Net Profit Margin | -230.87% |
| Debt/Equity Ratio | 7.8% |
How did A253840 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/14 01:34 |
| End of Day Share Price | 2026/03/13 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sugentech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.